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S U M M A R Y
Objectives: Proinﬂammatory cytokines and the oxidative stress response are reported to be involved in
dengue viral disease. The present study investigated the correlation of proinﬂammatory cytokines and
lipid peroxidation with dengue severity.
Methods: Clinical samples from 27 dengue fever (DF) cases, 30 dengue haemorrhagic fever (DHF) cases,
and 24 dengue shock syndrome (DSS) cases were studied around defervescence, along with samples
from 30 healthy controls. Plasma samples were analysed for tumour necrosis factor alpha (TNF-a) and
interferon gamma (IFN-g) by ELISA and for malondialdehyde (MDA) by thiobarbituric acid assay.
Results: Dengue-infected individuals had signiﬁcantly higher levels of TNF-a, IFN-g, and MDA in
comparison to controls. The ratio of TNF-a to IFN-g was signiﬁcantly higher in DHF and DSS than in DF. A
TNF-a/IFN-g ratio value of 5.69 around defervescence predicted DHF and DSS with moderate accuracy
and thus may serve as an indicator to study dengue severity. The study observed a signiﬁcant positive
correlation of lipid peroxides with TNF-a levels and the TNF-a/IFN-g ratio in severe dengue cases.
Conclusions: We propose that the oxidative stress response induced by the dengue virus may trigger the
inﬂammatory cytokine responses in dengue severity and thereby contributes to the pathogenesis of the
disease; however the interplay between the oxidative response and inﬂammatory activity in disease
virulence needs further study.
 2013 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious
Diseases. 
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Dengue virus (DENV), a mosquito-transmitted single-strand
virus, is prevalent in over 100 tropical and subtropical countries,
with an estimated 96 million apparent dengue infections
worldwide.1,2 Infection with DENV may result in an asymptomatic
or mild self-limiting acute febrile illness, dengue fever (DF), or life-
threatening severe illnesses, dengue haemorrhagic fever (DHF) and
dengue shock syndrome (DSS).3* Corresponding author. Tel.: +91 413 2296171; fax: +91 413 2272066.
** Corresponding author. Tel.: +91 4362 264101; fax: +91 4362 264120.
E-mail addresses: soundy27@yahoo.co.in (R. Soundravally),
agiesh@scbt.sastra.edu, agiesh.b@gmail.com (B.A. Kumar).
1201-9712  2013 The Authors. Published by Elsevier Ltd on behalf of International S
http://dx.doi.org/10.1016/j.ijid.2013.09.022The pathogenesis of dengue severity remains poorly under-
stood. Oxidative stress-induced damage has been observed in
patients post-DENV infection, suggesting that this could play a
role in the pathogenesis of DF or DHF/DSS.4 Earlier studies have
demonstrated that cells infected with herpes simplex virus and
human immunodeﬁciency virus exhibit an increased generation
of reactive oxygen species (ROS) with decreased antioxidant
production, leading to the activation of redox-dependent tran-
scription factors and the production of various cytokines.5,6
However, the association of ROS and cytokine production in DENV
infection has not been greatly explored. Our previous research and
other studies in this area have revealed a signiﬁcant pro-oxidant
state in dengue viral infection and its association with thrombo-
cytopenia.7–9 On the other hand, cytokines are reported to play a
signiﬁcant role in the evolution of severe dengue infection.10,11
The production and upregulation of cytokines in response to
DENV infection are responsible for the development of complica-
tions such as cerebral oedema, increased haematocrit, and
thrombocytopenia.12 Proinﬂammatory cytokines such as tumourociety for Infectious Diseases. Open access under CC BY-NC-ND license.
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been found to be particularly elevated in severe dengue and have
been associated with the severity of illness.13–19
Since no reports are available on the correlation between
inﬂammatory and oxidative stress responses and disease patho-
genesis, the present study aimed to evaluate the levels of plasma
malondialdehyde (MDA), a known reactive aldehyde formed by the
degradation of polyunsaturated lipids by ROS and a widely used
biomarker for the oxidative stress response,20 and the levels of
proinﬂammatory cytokines TNF-a and IFN-g during deferves-
cence, in all the three clinical groups of dengue (DF, DHF, and DSS),
compared to uninfected blood samples.
2. Materials and methods
2.1. Study design
Patients enrolled in the study were recruited from the
Jawaharlal Institute of Postgraduate Medicine and Research
(JIPMER) hospital, Pondicherry. Eighty-one dengue-infected adults
between the ages of 24 and 52 years, of whom 31 were female,
were selected for the study. Age- and gender-matched controls
(n = 30) were also recruited. Written informed consent was
obtained from all participants and the study was approved by
the ethics review committee of JIPMER.
Infected individuals were further classiﬁed into DF (n = 27),
DHF (n = 30), and DSS (n = 24) cases as per the World Health
Organization (WHO) grading system.21 Multiplex reverse tran-
scriptase PCR was done for the detection and typing of DENV as
described by Lanciotti et al.22 Out of 81 cases, 15 were positive for
DENV by RT-PCR, and DENV serotype 3 was identiﬁed as the
aetiological agent. Virus-negative samples were further subjected
to a one-step ELISA that detects the dengue-speciﬁc IgM and IgG
antibodies (Novatech, Germany). Normal controls were blood
donors who were negative for both anti-dengue IgM and IgG
antibodies and virus.
Blood samples were obtained from the patients at the time of
defervescence; 3 ml of blood was collected into a heparinized
bottle and centrifuged at 2500 g for 5 min to separate the plasma,
which was stored at 70 8C until analysis.
2.2. Assay for proinﬂammatory cytokines and lipid peroxidation
Plasma levels of TNF-a and IFN-g were estimated using the BD
OptEIA ELISA Kit (BD Biosciences, San Jose, CA, USA). Cytokine
concentrations were interpolated from the calibration curve as per
the manufacturer’s instructions. Plasma MDA was estimated by
Satoh method23 in which 0.5 ml of plasma was added to 20%Table 1
Characteristics of the study patients with the different clinical presentations of dengue
DF 
Number of patients 27 
Sex, male/female 0.92/1.0 
Age, years, median (range) 22 (16–67) 
Symptoms and signs, n (%)
Cough 10 (37) 
Headache 7 (25.9) 
Arthralgia 10 (37) 
Hepatomegaly 6 (22.2) 
Petechiae 11 (40.7) 
Clinical bleeding 3 (11.1) 
Maximum haematocrit, %, mean (SD) 33.1 (3.4) 
Minimum platelet count,  109/l, median (range) 105.6 (11.0–290
DF, dengue fever; DHF, dengue haemorrhagic fever; DSS, dengue shock syndrome; SD,
a p-Values were calculated by Chi-square test for binary variables and independent Stu
U-test for platelet count.
b ,cp < 0.05 when compared with DF and DHF cases, respectively.trichloroacetic acid (TCA) and centrifuged at 3500 rpm for 10 min.
The precipitate was washed with 0.05 M H2SO4 and resuspended in
0.05 M H2SO4 and 0.22% thiobarbituric acid (TBA). The mixture was
further heated at 100 8C for 30 min and extracted with n-butanol.
The colour that developed was measured spectrophotometrically
at 532 nm and the amount of MDA was determined from the
standard curve, as described previously.23 In this reaction MDA
reacts with TBA under acidic conditions to give a ﬁnal pink-
coloured product; the molar extinction coefﬁcient of the ﬁnal
coloured product of the assay was 1.56  105 M1cm1.
2.3. Statistical analysis
Data were analyzed using the statistical program SPSS for
Windows, version 13 (SPSS Inc., Chicago, IL, USA). Results are given
as the mean  standard deviation (SD). Platelet counts are expressed
as the median (range). The independent Student’s t-test was used for
comparisons of unpaired data between groups. The Mann–Whitney
U-test was used for comparisons of platelet counts (non-parametric
data). One-way analysis of variance (ANOVA) followed by the post-
hoc Tukey HSD test and Kruskal–Wallis tests were used to determine
differences in MDA, IFN-g, and TNF-a between different clinical
groups of dengue infection, for parametric and non-parametric data,
respectively. Relationships between MDA, IFN-g, and TNF-a levels
were evaluated using Pearson correlation for normally distributed
data and Spearman correlation for non-normally distributed data, and
the results expressed with the correlation coefﬁcient (r). Receiver
operating characteristic (ROC) curve analysis was performed to study
the proposed parameters for their predictive potential for severe
dengue disease. The Youden index (sensitivity + speciﬁcity  1) was
used as a measure of accuracy. A p-value of less than 0.05 was
considered statistically signiﬁcant.24
3. Results
3.1. Clinical characteristics of the study group
Clinical and haematological characteristics of dengue-infected
patients recruited into the study are shown in Table 1. Most of the
patients presented signs of defervescence on day 4 or 5 post-onset
of fever. DHF patients presented symptoms of headache, arthralgia,
and petechiae more frequently than DF patients (p < 0.001),
whereas both DHF and DSS cases had more frequent presentation
of hepatomegaly and clinical bleeding than DF cases. Higher peaks
of haematocrit were found in patients with DSS than patients with
DF and DHF (p < 0.001), and a similar difference was observed in
DHF compared to DF cases. DSS patients had a signiﬁcantly lower infectiona
DHF DSS
30 24
1.2/1.0 1.07/1.0
35 (20–59) 24 (16–65)
10 (33.3) 4 (16.7)
14 (46.7)b 6 (25)
21 (70)b 5 (20.8)
23 (76.7)b 10 (41.7)b
16 (53.3)b 8 (33.3)
23 (76.7)b 12 (50)b
36.3 (4.5)b 39.5 (6.3)b,c
.0) 55.0 (12.5–98.00)b 22.0 (10.0–82.0)b,c
 standard deviation.
dent’s t-test for continuous variables; the p-value was calculated by Mann–Whitney
Table 2
Comparison of lipid peroxides and proinﬂammatory cytokines in dengue-infected
subjects and controls
Variables Controls (n = 30) Dengue cases (n = 81) p-Valuea
MDA (mmol/l) 1.9  0.4 4.9  0.9 <0.001
TNF-a (pg/ml) 6.2  1.8 167.1  127 <0.001
IFN-g (pg/ml) 3.5  1.4 23  11.6 <0.001
TNF-a/IFN-g ratio 1.9  0.64 8.3  6.9 <0.001
MDA, malondialdehyde; TNF-a, tumour necrosis factor alpha; IFN-g, interferon
gamma.
a p-Values were calculated using the Kruskal–Wallis test and one-way analysis of
variance followed by post-hoc Tukey HSD test for non-parametric and parametric
data, respectively; p < 0.05 was considered statistically signiﬁcant.
Table 4
Correlation analysis of lipid peroxidation and proinﬂammatory cytokines in the
different study groupsa
Groups TNF-a vs.
MDA
IFN-g vs.
MDA
TNF-a/IFN-g vs.
MDA
All dengue cases (n = 81) r = 0.668
p < 0.001
r = 0.288
p = 0.009
r = 0.842
p < 0.001
DF (n = 27) r = 0.071
p = 0.726
r = 0.147
p = 0.464
r = 0.259
p = 0.192
DHF (n = 30) r = 0.409
P = 0.025
r = 0.220
p = 0.213
r = 0.397
p = 0.030
DSS (n = 24) r = 0.624
p = 0.001
r = 0.305
p = 0.146
r = 0.594
p = 0.002
TNF-a, tumour necrosis factor alpha; MDA, malondialdehyde; IFN-g, interferon
gamma; DF, dengue fever; DHF, dengue haemorrhagic fever; DSS, dengue shock
syndrome.
a r = correlation coefﬁcient; p < 0.05 was considered signiﬁcant.
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assessment among cases revealed positivity for DENV type 3.
3.2. Lipid peroxidation
To observe if DENV infection can induce oxidative stress, the
levels of MDA were measured as an indicator of the redox status.
Dengue-infected cases had high levels of lipid peroxidation when
compared to controls (p < 0.001) (Table 2). Within clinical groups,
MDA levels were higher in both DHF and DSS than DF cases, and a
signiﬁcant difference persisted even between DHF and DSS cases
(Table 3). These results indicate that DENV can induce oxidative
stress and the response is higher in severe cases.
3.3. Proinﬂammatory cytokine levels
Plasma levels of TNF-a, IFN-g, and their ratio were elevated in
the dengue-infected cases in comparison to controls (p < 0.001)
(Table 2). Within clinical groups, the IFN-g level was found to beFigure 1. ROC curve of the TNF-a/IFN-g ratio in blood samples around defervescence 
predictor of DHF; it has an AUC of 0.659, with sensitivity 70% and speciﬁcity 70% for the c
AUC of 0.836, with sensitivity 90% and speciﬁcity 70% for the cut-off of 5.69. (TNF-a,
characteristic; DHF, dengue haemorrhagic fever; AUC, area under the curve; DSS, deng
Table 3
Comparison of lipid peroxides and proinﬂammatory cytokines in the different clinical 
Variables DF (n = 27) DHF (n = 30) 
MDA (mmol/l) 3.9  0.6 5.2  0.7 
TNF-a (pg/ml) 102.2  37.4 148.7  107.6 
IFN-g (pg/ml) 28.3  18.5 19.1  3.0 
TNF-a/IFN-g ratio 5.0  3.5 8.2  7.6 
DF, dengue fever; DHF, dengue haemorrhagic fever; DSS, dengue shock syndrome; MDA
a p-Values were calculated using the Kruskal–Wallis test and one-way analysis of vari
respectively; p < 0.05 was considered statistically signiﬁcant.
b Indicates p-value when compared between DF and DHF.
c Indicates p-value when compared between DF and DSS.
d Indicates p-value when compared between DHF and DSS.lower in cases with the severe forms (DHF and DSS) than in DF
cases, whereas the TNF-a level was higher in DSS compared to both
DF and DHF cases (Table 3). The TNF-a/IFN-g ratio was found to be
higher in those with the severe forms than in DF patients, and a
similar difference was observed in DSS compared to DHF cases
(Table 3).
Analysis of the association between oxidative stress and the
proinﬂammatory response revealed a positive correlation between
TNF-a and MDA levels in all dengue-infected cases (r = 0.668;
p < 0.001). Among the clinical groups, a positive correlation was
observed in DHF (r = 0.409; p = 0.025) and DSS (r = 0.624;
p = 0.001) patients, whereas no such association was seen in DF
cases (Table 4). Unlike TNF-a, in the case of IFN-g, a negative
correlation was observed with MDA in all dengue-infected cases,
however no such signiﬁcant association was seen in any of the
clinical groups.for predicting severe dengue disease. (A) ROC curve of the TNF-a/IFN-g ratio as a
ut-off of 5.69. (B) ROC curve of the TNF-a/IFN-g ratio as a predictor of DSS; it has an
 tumour necrosis factor alpha; IFN-g, interferon gamma; ROC, receiver operating
ue shock syndrome.)
presentations of dengue infectiona
DSS (n = 24) p-Valueb p-Valuec p-Valued
5.7  0.5 <0.001 <0.001 0.017
263.1  160 0.251 <0.001 <0.001
21.3  3.0 <0.001 0.028 0.824
12.3  7.1 0.039 <0.001 0.034
, malondialdehyde; TNF-a, tumour necrosis factor alpha; IFN-g, interferon gamma.
ance followed by post-hoc Tukey HSD test for non-parametric and parametric data,
Table 5
Statistical differences in the TNF-a/IFN-g ratio using ROC analysis for predicting DHF and DSS
Group Cut-off of TNF-a/IFN-g Sensitivity Speciﬁcity Youden index AUC  SEM 95% CI p-Value
DHF 5.69 70 70 0.4 0.659  0.073 0.515–0.803 0.03
DSS 5.69 90 70 0.6 0.836  0.05 0.729–0.943 <0.001
TNF-a, tumour necrosis factor alpha; IFN-g, interferon gamma; ROC, receiver operating characteristic; DHF, dengue haemorrhagic fever; DSS, dengue shock syndrome; AUC,
area under the curve; SEM, standard error of the mean; CI, conﬁdence interval.
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positive correlation was observed in all dengue cases and also
among the severe clinical groups (Table 4). This indicates that an
association exists between the oxidative stress response and
cytokine release in dengue infection.
ROC curve analysis was performed to deﬁne the best cut-off
value of the TNF-a/IFN-g ratio for predicting DHF and DSS. The
value that had the maximum Youden index was chosen to be the
best cut-off. In both DHF and DSS cases, the best cut-off value of the
TNF-a/IFN-g ratio was determined to be 5.69 (Figure 1, Table 5).
For DHF this carried a sensitivity of 70%, speciﬁcity of 70%, and an
area under the curve (AUC) of 0.659; for DSS this carried a
sensitivity of 90%, speciﬁcity of 70%, and an AUC of 0.836. Thus it is
evident that the TNF-a/IFN-g ratio would be effective in predicting
the severe forms of dengue disease.
4. Discussion
The present study compared the plasma levels of proinﬂam-
matory cytokines TNF-a and IFN-g and the oxidative stress
response molecule MDA around defervescence in a group of
dengue-infected cases reported during a dengue outbreak in
southern India. The aetiological agent was identiﬁed as DENV type
3. The duration of fever in dengue ranges from 3 to 5 days, and this
is followed by a sudden drop in temperature, which determines
recovery, or the development of plasma leakage manifesting as
DHF at or around the time of defervescence. The development of
DHF is presumed to occur when there is an aberrant activation of
immune cells secreting cytokines and other chemical mediators
that can cause vascular leakage and shock.11–13 Since cytokines
play a signiﬁcant role as markers of dengue disease severity,
studying these during defervescence would lead to the identiﬁca-
tion of biomarkers that may be used as an indicator to differentiate
between normal DF and severe dengue.
The mean plasma levels of IFN-g, an antiviral cytokine
produced by T-lymphocyte helper cells, were signiﬁcantly higher
in dengue-infected cases compared to controls, however the mean
IFN-g levels were signiﬁcantly lower in patients with DHF and DSS
than in those with DF. The results are similar to those reported
previously in DENV-infected Columbian infants, in whom serum
levels of IFN-g were lower in cases with DHF than in cases with
DF.25 This may be due to the IFN-g level, which peaks before
defervescence and drops drastically in the later stages of illness in
DHF.26 In contrast, some of the earlier studies reported higher
levels of IFN-g in severe dengue.27–30 The variation in the results
may be because of the variability in dengue serotypes, the time of
sample collection, the transient nature of cytokine production, and
genetic differences between the study populations.
In previous studies, TNF-a has been reported to be associated
with severity in DHF.18,19,31 Although other proinﬂammatory
cytokines can alter disease severity, studies have shown the
independent role of TNF-a in the induction of vascular leakage, and
the direct relationship between enhanced TNF-a levels and dengue
haemorrhage has been established in a mouse model.32–34 In the
present study, we observed a higher level of TNF-a in cases with
DSS and DHF than in cases with DF and a positive relationship
between the TNF-a and hematocrit in severe dengue disease.However some studies have not recorded a signiﬁcant elevation in
the TNF-a level in severe dengue cases.30,35,36 The variations in
TNF-a levels in different studies are probably the result of
differences in virus serotype, time of sample collection, clinical
presentation of the cases and mutations in the host TNF-a.
The present study did not observe any statistical difference in
the levels of IFN-g and TNF-a in DHF patients compared to DSS and
DF patients, respectively, however the ratio of TNF-a to IFN-g was
observed to be signiﬁcantly different between the clinical groups.
A ratio value of 5.69 could predict the development of DHF and DSS
around defervescence with moderate accuracy (Table 5).
Our previous studies, along with other research on free radical
status in dengue, has underlined the importance of oxidative stress
in the pathogenesis of dengue.7–9 The free radical release during
dengue viral infection is reported to upregulate the production of
proinﬂammatory cytokines.37 We have previously observed a
signiﬁcant increase in oxidative markers of protein and lipid injury
during the early phase of dengue infection.38 The present study
estimated the level of MDA in all the clinical groups to see if an
alteration in the redox status has any association with the
proinﬂammatory status. MDA levels were found to be signiﬁcantly
increased in all the test groups compared to the uninfected control
group. Similar to the expression pattern of TNF-a, the level of MDA
appeared to be higher in the severe disease groups compared to the
DF cases. Thus, a signiﬁcant positive association was observed
between this marker of lipid oxidation injury and the TNF-a level
in cases with severe disease. In the study of Wang et al.,
signiﬁcantly elevated levels of TNF-a were observed in DENV
type 2 infected mice, whereas reduced TNF-a levels were obtained
in the presence of antioxidant.39 This shows that the presence of
antioxidants could inhibit the release of proinﬂammatory cyto-
kines by inhibiting the virus-induced oxidative stress response and
associated oxidative injury. The results of the present study
support this concept by showing an elevated levels of MDA and the
proinﬂammatory cytokine TNF-a upon dengue viral infection.
Thus a signiﬁcant positive association between the marker of lipid
oxidation injury and TNF-a levels in cases with severe disease has
been observed in the current study. The study did not record any
signiﬁcant correlation between IFN-g and MDA in severe forms,
although a weak negative association was observed among all
dengue-infected cases, which could be due to the expression
pattern of IFN-g dropping in the later stages of the illness in the
severe forms.27 The ratio of TNF-a to IFN-g was found to be
positively correlated with MDA in all the three clinical groups
(Table 4), which leads to the understanding that inﬂammatory
cytokines are associated with oxidative stress responses in dengue
infection. However further studies are needed to determine the
exact mechanism of the interactions between the inﬂammatory
response and the oxidative stress response.
In summary, the present study suggests a possible interplay of
proinﬂammatory cytokines and oxidative stress in the immuno-
pathogenesis of severe dengue disease. We propose that dengue
virus may induce an oxidative stress response, which in turn
activates the release of proinﬂammatory cytokines, leading to
severe dengue. Since supplemental antioxidants could inhibit
oxidative stress and reduce the proinﬂammatory cytokine release,
we suggest that antioxidants may be useful as adjuvant therapy for
R. Soundravally et al. / International Journal of Infectious Diseases 18 (2014) 68–7272dengue. We further conclude that the TNF-a to IFN-g ratio around
defervescence may serve as an indicator to predict disease severity
in dengue-infected subjects.
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